Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation for treating coronary heart disease and cerebral thrombosis and production method of preparation

A production method and cerebral thrombosis technology, applied in the field of traditional Chinese medicine preparations and its production, can solve the problems of single excipients, unscientific combination, unsatisfactory therapeutic effect, etc.

Inactive Publication Date: 2018-05-04
广西体魄金生物科技股份有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are the following problems in the treatment of coronary heart disease and cerebral thrombosis preparations currently on the market: 1. Most of the product designs are simply supplemented with a combination of Chinese herbal medicine extracts, the combination is not scientific enough, the treatment effect is not ideal, and the symptoms are not cured; 2. Although some products are compound preparations, but did not consider the specificity and combination effects of various nutrients absorbed, the product formula lacks scientific and rationality, and the therapeutic effect is not ideal; 3. The excipients of traditional products are single, especially the taste factor is ignored, resulting in the practicability of the product Not strong

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation for treating coronary heart disease and cerebral thrombosis and production method of preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] According to one aspect of the present invention, this embodiment provides a preparation for treating coronary heart disease and cerebral thrombosis, the preparation is composed of the following raw materials in proportion by weight: 150 parts of Panax notoginseng extract, 100 parts of Dangui bark extract, Salvia miltiorrhiza 30 parts of extract, 3 parts of Tianshen extract, 8 parts of Astragalus extract, 2 parts of licorice extract, 3 parts of Ophiopogon japonicus extract, 3 parts of Schisandra extract, 3 parts of Coptis chinensis extract, 3 parts of Turmeric extract, 5 parts of Scutellaria baicalensis extract, 3 parts of Rhizoma Chuanxiong extract, 1.4 parts of earthworm, 0.6 part of hirudin, 8 parts of lemon, 0.5 part of velvet antler, 0.5 part of musk, and the purity of said hirudin is 99%.

[0050] According to another aspect of the present invention, this embodiment provides a kind of preparation method for treating coronary heart disease and cerebral thrombosis, c...

Embodiment 2

[0063] According to one aspect of the present invention, this embodiment provides a preparation for treating coronary heart disease and cerebral thrombosis, the preparation is composed of the following raw materials in proportion by weight: 100 parts of Panax notoginseng extract, 150 parts of Dangui bark extract, Salvia miltiorrhiza 70 parts of extract, 7 parts of Tianshen extract, 12 parts of Astragalus extract, 5 parts of licorice extract, 7 parts of Ophiopogon japonicus extract, 7 parts of Schisandra extract, 7 parts of Coptis chinensis extract, 8 parts of turmeric extract, 9 parts of scutellaria baicalensis extract, 6 parts of Chuanxiong extract, 6.5 parts of earthworm, 1.6 parts of hirudin, 15 parts of lemon, 1.4 parts of antler, and 1.5 parts of musk. The purity of the hirudin is 99.8%.

[0064] According to another aspect of the present invention, this embodiment provides a kind of preparation method for treating coronary heart disease and cerebral thrombosis, comprising...

Embodiment 3

[0077] According to one aspect of the present invention, this embodiment provides a preparation for treating coronary heart disease and cerebral thrombosis, the preparation is composed of the following raw materials in proportion by weight: 120 parts of Panax notoginseng extract, 130 parts of Dangui bark extract, Danshen 60 parts of extract, 5 parts of Tianshen extract, 10 parts of Astragalus extract, 4 parts of licorice extract, 5 parts of Ophiopogon japonicus extract, 5 parts of Schisandra extract, 6 parts of Coptis chinensis extract, 7 parts of Turmeric extract, 7 parts of skullcap extract, 5 parts of Chuanxiong extract, 3 parts of earthworm, 1 part of hirudin, 12 parts of lemon, 1 part of antler and 1.2 parts of musk. The purity of the hirudin is 99.6%.

[0078] According to another aspect of the present invention, this embodiment provides a kind of preparation method for treating coronary heart disease and cerebral thrombosis, comprising the following steps:

[0079] Step...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a preparation for treating coronary heart disease and cerebral thrombosis. The preparation is prepared from the following raw materials in parts by weight: 100-150 parts of a pseudo-ginseng extract, 100-150 parts of an orange osmanthus bark extract, 30-70 parts of radix salviae miltiorrhizae extract, 3-7 parts of Tianseng extract, 8-12 parts of a radix astragali extract, 2-5 parts of a liquorice extract, 3-7 parts of a radix ophiopogonis extract, 3-7 parts of a fructus schisandrae chinensis extract, 3-7 parts of a rhizoma coptidis extract, 3-8 parts of a radix curcumaeextract, 5-9 parts of a radix scutellariae extract, 3-6 parts of a rhizoma chuanxiong extract, 1.4-6.5 parts of pheretima, 0.6-1.6 parts of hirudin, 8-15 parts of lemons. 0.5-1.4 parts of corn cervi pantotrichum and 0.5-1.5 parts of moschus. The invention further discloses a preparation method of the preparation. The preparation method comprises the steps of respectively extracting the raw materials, uniformly mixing by virtue of an equivalent incremental method, and sieving by virtue of an 80-mesh sieve. By virtue of the scientific compatibility of purely natural Chinese herbal medicines, thepreparation has the efficacies of tonifying vital energy and blood, nourishing and activating blood and removing stasis and has remarkable effects on the treatment of coronary heart disease and cerebral thrombosis.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine preparations and production thereof, in particular to a preparation for treating coronary heart disease and cerebral thrombosis and a production method thereof. Background technique [0002] Cardiovascular and cerebrovascular diseases are collectively referred to as cardiovascular diseases and cerebrovascular diseases. Among them, diseases that occur in the arteries of the heart are called cardiovascular diseases, mainly including coronary heart disease, myocardial infarction, and hypertension. Diseases that occur in cerebral arteries are called cerebrovascular diseases, mainly including cerebral hemorrhage, cerebral thrombosis, and cerebral embolism. It is caused by arteriosclerosis, hypertension, hyperlipidemia, hyperglycemia, hyperviscosity and microcirculation disorder, and is a major disease that seriously threatens human health. The number of people who die from cardiova...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/58A61K36/9066A61P9/10A61K35/62A61K35/55A61K35/32
CPCA61K35/32A61K35/55A61K35/62A61K36/236A61K36/258A61K36/481A61K36/484A61K36/537A61K36/539A61K36/54A61K36/57A61K36/718A61K36/752A61K36/79A61K36/8968A61K36/9066A61K38/58A61K2236/331A61K2236/39A61K2236/51A61K2236/55A61K2300/00
Inventor 阙锋
Owner 广西体魄金生物科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products